October 28th 2024
"The novel RSV prevention strategies may reduce ICU morbidity and mortality for children," the study authors concluded.
AAP letter urges the start of COVID-19 vaccine trials in young children
February 26th 2021A safe coronavirus 2019 disease (COVID-19) vaccine that can be administered to most of the pediatric population is a necessity for ending the pandemic, but trials for younger children have not occurred. The president of the American Academy of Pediatrics (AAP) wrote to key COVID-19 officials about the need to change this.
Are primary prevention strategies altering the course of the perfect storm?
February 23rd 2021As the 2020-2021 influenza season loomed, many in health care worried that the seasonal disease would add to the extraordinary burden of coronavirus disease 2019 and create a perfect storm. Have various prevention strategies helped prevent this potential issue?
Pfizer COVID-19 vaccine receives emergency use authorization
December 14th 2020Following the green light from the vaccine advisory committee, the US Food and Drug Administration has given emergency use authorization for the Pfizer/BioNTech COVID-19 vaccine, making it the first vaccine for COVID-19 approved for use in the United States.
Tackling parental concerns about chemicals in vaccines and the home
October 4th 2020We may have grown used to chemicals being a part of everyday life, but some will cause many parents to worry. A presentation at the virtual 2020 American Academy of Pediatrics National Conference & Exhibition offers guidance on how to address these concerns.
Let’s proactively stop another public health nightmare!
August 20th 2020This is the critical moment in time for all health care providers to proactively stop this potential public health nightmare by speaking with all parents and adolescents about the absolute need for everyone to receive the influenza vaccine.
Can a RSV vaccine administered during pregnancy be effective in preventing infection during infancy?
August 10th 2020A study looks at whether a vaccine for respiratory syncytial virus (RSV) could be effective in reducing RSV-associated, medically significant lower respiratory tract infections in infants.